Literature DB >> 2598968

Effect of short-term omeprazole administration on serum pepsinogens in relation to fasting serum gastrin and gastric acid secretion.

I Biemond1, L F Crobach, J B Jansen, C B Lamers.   

Abstract

A study has been done in 10 male healthy volunteers of the effect of oral omeprazole 20 mg daily for 3 days on the serum concentrations of Pepsinogens A and C in relation to changes in fasting serum gastrin and basal and pentagastrin stimulated gastric acid output. The concentrations of Pepsinogens A and C showed concomitant and variable but significant increases, and the Pepsinogen A, C ratio did not change during the 3-day course of omeprazole. The increments were also significantly correlated with the increase in fasting serum gastrin and with the reduction in pentagastrin stimulated acid output. The correlations were mainly due to the marked inhibition of gastric acid secretion and the corresponding increases in serum gastrin and Pepsinogens A and C in two subjects, as in the other 8 subjects the changes were only modest. There appears to be a relationship, therefore, between the degree of inhibition of acid by omeprazole and the parallel increases in both serum pepsinogens and fasting gastrin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2598968     DOI: 10.1007/bf00558498

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  A study of the relationship between serum group I pepsinogen levels and gastric acid secretion.

Authors:  I M Samloff; D M Secrist; E Passaro
Journal:  Gastroenterology       Date:  1975-12       Impact factor: 22.682

2.  Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels.

Authors:  H P Festen; H A Tuynman; J Défize; G Pals; R R Frants; J P Straub; S G Meuwissen
Journal:  Dig Dis Sci       Date:  1986-06       Impact factor: 3.199

3.  Use of an inert marker (phenol red) to improve accuracy in gastric secretion studies.

Authors:  M Hobsley; W Silen
Journal:  Gut       Date:  1969-10       Impact factor: 23.059

4.  Effect of oral omeprazole on serum gastrin and serum pepsinogen I levels.

Authors:  H P Festen; J C Thijs; C B Lamers; J M Jansen; G Pals; R R Frants; J Défize; S G Meuwissen
Journal:  Gastroenterology       Date:  1984-11       Impact factor: 22.682

5.  Serum group I pepsinogens and gastrin in relation to gastric H+ and pepsin outputs before and after subcutaneous injection of pentagastrin.

Authors:  H L Waldum; P G Burhol; B K Straume
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

6.  Radioimmunoassay of human pepsinogen A and pepsinogen C.

Authors:  I Biemond; J B Jansen; L F Crobach; J Kreuning; C B Lamers
Journal:  J Clin Chem Clin Biochem       Date:  1989-01

7.  Inhibition of gastric acid secretion by omeprazole and ranitidine. Effects on plasma gastrin and gastric histamine, histidine decarboxylase activity and ECL cell density in normal and antrectomized rats.

Authors:  F Sundler; E Carlsson; R Håkanson; H Larsson; H Mattsson
Journal:  Scand J Gastroenterol Suppl       Date:  1986

8.  Effect of changes in serum calcium on secretin-stimulated serum gastrin in patients with Zollinger-Ellison syndrome.

Authors:  J B Jansen; C B Lamers
Journal:  Gastroenterology       Date:  1982-07       Impact factor: 22.682

9.  Comparison of gastric acid secretion rates and serum pepsinogen I and II concentrations in Occidental and Oriental duodenal ulcer patients.

Authors:  M Feldman; C T Richardson; S K Lam; I M Samloff
Journal:  Gastroenterology       Date:  1988-09       Impact factor: 22.682

10.  Dissociation of pepsinogen and acid secretion in the guinea pig.

Authors:  M D Basson; T E Adrian; I M Modlin
Journal:  Gastroenterology       Date:  1988-08       Impact factor: 22.682

View more
  6 in total

1.  Weekend treatment with 20 and 40 mg omeprazole: effect on intragastric pH, fasting and postprandial serum gastrin, and serum pepsinogens.

Authors:  L C Baak; J B Jansen; I Biemond; C B Lamers
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

2.  Serum pepsinogens after interruption of long-term maintenance therapy with omeprazole in patients with reflux esophagitis.

Authors:  I Biemond; E C Klinkenberg-Knol; C B Lamers; S G Meuwissen
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

3.  Inhibition of omeprazole induced hypergastrinaemia by SMS 201-995, a long acting somatostatin analogue in man.

Authors:  J L Meijer; J B Jansen; L F Crobach; I Biemond; C B Lamers
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

4.  Effect of synthetic prostaglandin E2 analog enprostil on omeprazole-induced hypergastrinemia and hyperpepsinogenemia.

Authors:  J L Meijer; L F Crobach; J B Jansen; C B Lamers
Journal:  Dig Dis Sci       Date:  1994-03       Impact factor: 3.199

5.  Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A.

Authors:  I Biemond; J Kreuning; J B Jansen; C B Lamers
Journal:  Gut       Date:  1993-10       Impact factor: 23.059

6.  Helicobacter pylori infection and serum pepsinogen I concentration in peptic ulcer patients: effect of bacterial eradication.

Authors:  S M Park; J Park; S K Chang; B C Yoo; H J Kim
Journal:  Korean J Intern Med       Date:  1996-01       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.